Even though our key medicines have many generic competitors, their reputation and experience among payers, prescribers and patients has and continues to set them apart
In Conversation
"Pharmaceutical companies need to be able to have easy access to even more locations to ensure that their products reach their ultimate customers without compromising product…
"A key priority is making (medical) nutrition better understood by the relevant stakeholders so it can be seen as therapy and not just calories or food."
"It made perfect sense to move to Singapore entirely and leverage on the country’s core strengths."
"Starting out in any other place within the region like China, Japan, Korea, or Indonesia, you would have to speak the language and understand the culture,…
"The ASEAN region is unique in that it presents a full range of healthcare needs."
"Healthcare is still in the early stages of convergence with technology, but there will be sweeping changes across the entire vertical in the next 10 years"
"Singapore will continue acting as a centralized hub for all activities in the APAC region, effectively driving the whole spectrum of capabilities such as supply chain,…
We need to think along the lines of what it takes to make healthcare providers successful, as opposed to just focusing on promoting products
As regulatory conditions change on a consistent basis, it is imperative to sustain a dialogue with governments and regulatory authorities to address requirements and conduct operations…
We believe that there are unlimited opportunities in Asia Pacific to transform healthcare
"There are no true biotechs listed in Singapore today, and that just really comes down the level of risk that investors are willing to take."
